Sarcopenia is Associated with Reduced Survival following Surgery for Adrenocortical Carcinoma
- 3 August 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Endocrine Research
- Vol. 47 (1), 8-17
- https://doi.org/10.1080/07435800.2021.1954942
Abstract
Adrenocortical cancer (ACC) is an aggressive malignancy and robust prognostic factors remain unclear. The presence of sarcopenia has been shown to negatively impact survival for other malignancies, but has not been extensively analyzed in ACC. Patients who underwent resection of their ACC between 2010 and 2020 were identified; therapeutic, operative, and outcome data were analyzed. Sarcopenia was assessed by calculation of the skeletal muscle index (SMI) and was defined as an SMI 2/m2 for males and 2/m2 for females. Data on 35 patients (18 F: 17 M; median age 54 [range: 18–86]) who had primary surgical treatment were analyzed. Median tumor size was 10 cm [range:3–15]. In eleven patients (31%), the tumor was hormonally active (cortisol = 8;23%). Seventeen patients (49%) were classified as having sarcopenia on their pre-operative CT scan. The Intraclass Correlation Coefficient (ICC) for intra- and inter-observer variability showed very good agreement (0.99 and 0.98). There was no difference in incidence of sarcopenia stratifying for sex, BMI, or tumor-size, but incidence was higher with increasing age (p < .05). Overall median survival was 36 months, with 1- and 3-year survival rates of 77% and 52%. The presence of sarcopenia was strongly associated with a shorter overall survival (HR = 3.21; [95%CI: 1.06–9.69];p = .03) on unadjusted analyses. Moreover, age, higher T-stage, and presence of capsular invasion were also associated with poorer survival on univariable analyses. The presence of sarcopenia in patients undergoing surgery for ACC could be a predictor of reduced overall survival, although replications of these analyses should be performed in similar, larger cohorts. Specifically, the influence of a patient’s hormonal status on the manifestation of sarcopenia should be further defined.Keywords
Funding Information
- report no proprietary or commercial interest in any product mentioned or concept discussed in this article
This publication has 49 references indexed in Scilit:
- Laparoscopic versus open adrenalectomy: Another look at outcome using the Clavien classification systemSurgery, 2012
- Worsening Central Sarcopenia and Increasing Intra‐Abdominal Fat Correlate with Decreased Survival in Patients with Adrenocortical CarcinomaWorld Journal of Surgery, 2012
- A quantitative tool to assess degree of sarcopenia objectively in patients with hypercortisolismSurgery, 2011
- Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasisHPB, 2011
- Adrenocortical carcinoma: a clinician's updateNature Reviews Endocrinology, 2011
- Clinical management of adrenocortical carcinomaBest Practice & Research Clinical Endocrinology & Metabolism, 2009
- Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinomaCancer, 2009
- Clinical and Biological Features in the Prognosis of Adrenocortical Cancer: Poor Outcome of Cortisol-Secreting Tumors in a Series of 202 Consecutive PatientsJournal of Clinical Endocrinology & Metabolism, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Pathologic Features of Prognostic Significance in Adrenocortical CarcinomaThe American Journal of Surgical Pathology, 1989